Bacillary angiomatosis in an immunosuppressed dog

Veterinary Dermatology

Volumn 21, Issue 4, 2010, Pages 420-428

  Yager, Julie A ^a,b   Best, Susan J ^a   Maggi, Ricardo G ^c   Varanat, Mrudula ^c   Znajda, Nadine ^d   Breitschwerdt, Edward B ^c  

^a Yager Best Veterinary Surgical Pathology   (Canada)

^b UNIVERSITY OF GUELPH   (Canada)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d Florida Veterinary Specialists   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZATHIOPRINE; AZITHROMYCIN; CLINDAMYCIN; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CASE REPORT; DOG; FEMALE; HEMANGIOMATOSIS; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; PANCYTOPENIA;

ANGIOMATOSIS, BACILLARY; ANIMALS; ANTI-BACTERIAL AGENTS; AZATHIOPRINE; AZITHROMYCIN; CLINDAMYCIN; DOGS; FEMALE; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; PANCYTOPENIA; PREDNISONE;

BACILLI (CLASS); BARTONELLA; BARTONELLA HENSELAE; BARTONELLA QUINTANA; BARTONELLA VINSONII; BARTONELLA VINSONII SUBSP. BERKHOFFII; CANIS FAMILIARIS;

EID: 77954379644     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2010.00879.x     Document Type: Article

References (52)

1. Breitschwerdt EB, Kordick DL. Bartonella infection in animals: carriership, reservoir potential, pathogenicity, and zoonotic potential for human infection. Clinical Microbiology Reviews 2000, 13:428-38.
2. Chomel BB, Boulouis HJ, Maruyama S. Bartonella spp. in pets and effect on human health. Emerging Infectious Diseases 2006, 12:389-94.
3. Florin TA, Zaoutis TE, Zaoutis LB. Beyond cat scratch disease: widening spectrum of Bartonella henselae infection. Pediatrics 2008, 121:e1413-25.
4. Foucault C, Brouqui P, Raoult D. Bartonella quintana characteristics and clinical management. Emerging Infectious Diseases 2006, 12:217-23.
5. Dehio C. Molecular and cellular basis of bartonella pathogenesis. Annual Review of Microbiology 2004, 58:365-90.
6. Kordick DL, Breitschwerdt EB. Intraerythrocytic presence of Bartonella henselae. Journal of Clinical Microbiology 1995, 33:1655-6.
7. Billeter SA, Levy MG, Chomel BB. Vector transmission of Bartonella species with emphasis on the potential for tick transmission. Medical Veterinary Entomology 2008, 22:1-15.
8. Schwartzman W. Bartonella (Rochalimaea) infections: beyond cat scratch. Annual Review of Medicine 1996, 47:355-64.
9. Ihler GM. Bartonella bacilliformis: dangerous pathogen slowly emerging from deep background. FEMS Microbiology Letters 1996, 144:1-11.
10. Jacomo V, Kelly PJ, Raoult D. Natural history of Bartonella infections (an exception to Koch's postulate). Clinical Diagnostic Laboratory Immunology 2002, 9:8-18.
11. Saenz HL, Engel P, Stoeckli MC. Genomic analysis of Bartonella identifies type IV secretion systems as host adaptability factors. Nature Genetics 2007, 39:1469-76.
12. Mandle T, Einsele H, Schaller M. Infection of human CD34+ progenitor cells with Bartonella henselae results in intraerythrocytic presence of B. henselae. Blood 2005, 106:1215-22.
13. Munana KR, Vitek SM, Hegarty BC. Infection of fetal feline brain cells in culture with Bartonella henselae. Infection and Immunity 2001, 69:564-9.
14. Manders SM. Bacillary angiomatosis. Clinical Dermatology 1996, 14:295-9.
15. Schweyer S, Fayyazi A. Activation and apoptosis of macrophages in cat scratch disease. Journal of Pathology 2002, 198:534-40.
16. Duncan AW, Maggi RG, Breitschwerdt EB. A combined approach for the enhanced detection and isolation of Bartonella species in dog blood samples: pre-enrichment liquid culture followed by PCR and subculture onto agar plates. Journal of Microbiological Methods 2007, 69:273-81.
17. Maggi RG, Breitschwerdt EB. Potential limitations of the 16S-23S rRNA intergenic region for molecular detection of Bartonella species. Journal of Clinical Microbiology 2005, 43:1171-6.
18. Maggi RG, Duncan AW, Breitschwerdt EB. Novel chemically modified liquid medium that will support the growth of seven Bartonella species. Journal of Clinical Microbiology 2005, 43:2651-5.
19. Breitschwerdt EB, Kordick DL, Malarkey DE. Endocarditis in a dog due to infection with a novel Bartonella subspecies. Journal of Clinical Microbiology 1995, 33:154-60.
20. Kordick DL, Swaminathan B, Greene CE. Bartonella vinsonii subsp. berkhoffii subsp. nov., isolated from dogs; Bartonella vinsonii subsp. vinsonii; and emended description of Bartonella vinsonii. International Journal of Systematic Bacteriology 1996, 46:704-9.
21. Breitschwerdt EB, Blann KR, Stebbins ME. Clinicopathological abnormalities and treatment response in 24 dogs seroreactive to Bartonella vinsonii (berkhoffii) antigens. Journal of American Animal Hospital Association 2004, 40:92-101.
22. Pappalardo BL, Correa MT, York CC. Epidemiologic evaluation of the risk factors associated with exposure and seroreactivity to Bartonella vinsonii in dogs. American Journal of Veterinary Research 1997, 58:467-71.
23. Chang CC, Kasten RW, Chomel BB. Coyotes (Canis latrans) as the reservoir for a human pathogenic Bartonella sp.: molecular epidemiology of Bartonella vinsonii subsp. berkhoffii infection in coyotes from central coastal California. Journal of Clinical Microbiology 2000, 38:4193-200.
24. Henn JB, Vanhorn BA, Kasten RW. Antibodies to Bartonella vinsonii subsp. berkhoffii in Moroccan dogs. American Journal of Tropical Medicine and Hygiene 2006, 74:222-3.
25. Kitchell BE, Fan TM, Kordick D. Peliosis hepatis in a dog infected with Bartonella henselae. Journal of American Veterinary Medical Association 2000, 216:519-23.
26. Gillespie TN, Washabau RJ, Goldschmidt MH. Detection of Bartonella henselae and Bartonella clarridgeiae DNA in hepatic specimens from two dogs with hepatic disease. Journal of American Veterinary Medical Association 2003, 222:47-51. 35
27. Solano-Gallego L, Bradley J, Hegarty B. Bartonella henselae IgG antibodies are prevalent in dogs from southeastern USA. Veterinary Research 2004, 35:585-95.
28. Chomel BB, Mac Donald KA, Kasten RW. Aortic valve endocarditis in a dog due to Bartonella clarridgeiae. Journal of Clinical Microbiology 2001, 39:3548-54.
29. Boulouis HJ, Chang CC, Henn JB. Factors associated with the rapid emergence of zoonotic Bartonella infections. Veterinary Research 2005, 36:383-410.
30. Cross JR, Rossmeisl JH, Maggi RG. Bartonella-associated meningoradiculoneuritis and dermatitis or panniculitis in 3 dogs. Journal of Veterinary Internal Medicine 2008, 22:674-8.
31. Mellor PJ, Fetz K, Maggi RG. Alpha1-proteinase inhibitor deficiency and Bartonella infection in association with panniculitis, polyarthritis, and meningitis in a dog. Journal of Veterinary Internal Medicine 2006, 20:1023-8.
32. Michau TM, Breitschwerdt EB, Gilger BC. Bartonella vinsonii subspecies berkhoffi as a possible cause of anterior uveitis and choroiditis in a dog. Veterinary Ophthalmology 2003, 6:299-304.
33. Pappalardo BL, Brown T, Gookin JL. Granulomatous disease associated with Bartonella infection in 2 dogs. Journal of Veterinary Internal Medicine 2000, 14:37-42.
34. Breitschwerdt EB, Atkins CE, Brown TT. Bartonella vinsonii subsp. berkhoffii and related members of the alpha subdivision of the Proteobacteria in dogs with cardiac arrhythmias, endocarditis, or myocarditis. Journal of Clinical Microbiology 1999, 37:3618-26.
35. LeBoit PE, Berger TG, Egbert BM. Bacillary angiomatosis. The histopathology and differential diagnosis of a pseudoneoplastic infection in patients with human immunodeficiency virus disease. American Journal of Surgical Pathology 1989, 13:909-20.
36. Cockerell CJ, Whitlow MA, Webster GF. Epithelioid angiomatosis: a distinct vascular disorder in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Lancet 1987, 2:654-6.
37. Plettenberg A, Lorenzen T, Burtsche BT. Bacillary angiomatosis in HIV-infected patients - an epidemiological and clinical study. Dermatology 2000, 201:326-31.
38. Simpson KW, Dogan B, Rishniw M. Adherent and invasive Escherichia coli is associated with granulomatous colitis in boxer dogs. Infection and Immunity 2006, 74:4778-92.
39. Stoler MH, Bonfiglio TA, Steigbigel RT. An atypical subcutaneous infection associated with acquired immune deficiency syndrome. American Journal of Clinical Pathology 1983, 80:714-8.
40. Angritt P, Tuur SM, Macher AM. Epithelioid angiomatosis in HIV infection: neoplasm or cat-scratch disease? Lancet 1988, 1:996.
41. Relman DA. The identification of uncultured microbial pathogens. Journal of Infectious Diseases 1993, 168:1-8.
42. Brenner DJ, O'Connor SP, Winkler HH. Proposals to unify the genera Bartonella and Rochalimaea, with descriptions of Bartonella quintana comb. nov., Bartonella vinsonii comb. nov., Bartonella henselae comb. nov., and Bartonella elizabethae comb. nov., and to remove the family Bartonellaceae from the order Rickettsiales. International Journal of Systematic Bacteriology 1993, 43:777-86.
43. Kempf VA, Volkmann B, Schaller M. Evidence of a leading role for VEGF in Bartonella henselae-induced endothelial cell proliferations. Cellular Microbiology 2001, 3:623-32.
44. Kordick SK, Breitschwerdt EB, Hegarty BC. Coinfection with multiple tick-borne pathogens in a Walker Hound kennel in North Carolina. Journal of Clinical Microbiology 1999, 37:2631-8.
45. Kirby JE, Nekorchuk DM. Bartonella-associated endothelial proliferation depends on inhibition of apoptosis. Proceedings of the National Academy of Sciences, USA 2002, 99:4656-61.
46. Pappalardo BL, Brown T, Gebhardt D. Cyclic CD8+ lymphopenia in dogs experimentally infected with Bartonella vinsonii subsp. berkhoffii. Veterinary Immunology and Immunopathology 2000, 75:43-57.
47. Pappalardo BL, Brown TT, Tompkins M. Immunopathology of Bartonella vinsonii (berkhoffii) in experimentally infected dogs. Veterinary Immunology and Immunopathology 2001, 83:125-47.
48. Dehio C. Bartonella-host-cell interactions and vascular tumour formation. Nature Reviews Microbiology 2005, 3:621-31.
49. Dehio C. Recent progress in understanding Bartonella-induced vascular proliferation. Current Opinions in Microbiology 2003, 6:61-5.
50. Meghari S, Rolain JM, Grau GE. Antiangiogenic effect of erythromycin: an in vitro model of Bartonella quintana infection. Journal of Infectious Diseases 2006, 193:380-6.
51. Salvatore P, Casamassimi A, Sommese L. Detrimental effects of Bartonella henselae are counteracted by l-arginine and nitric oxide in human endothelial progenitor cells. Proceedings of the National Academy of Sciences, USA 2008, 105:9427-32.
52. Mexas AM, Hancock SI, Breitschwerdt EB. Bartonella henselae and Bartonella elizabethae as potential canine pathogens. Journal of Clinical Microbiology 2002, 40:4670-4.